# Toripalimab Combined With Radiotherapy and S-1 for Older Patients With Esophageal Cancer

> **NCT06009705** · — · UNKNOWN · sponsor: **Hebei Medical University Fourth Hospital** · enrollment: 56 (estimated)

## Conditions studied

- Esophageal Carcinoma

## Interventions

- **DRUG:** toripalimab

## Key facts

- **NCT ID:** NCT06009705
- **Lead sponsor:** Hebei Medical University Fourth Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-10-01
- **Primary completion:** 2025-04-30
- **Final completion:** 2026-04-30
- **Target enrollment:** 56 (ESTIMATED)
- **Last updated:** 2023-08-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06009705

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06009705, "Toripalimab Combined With Radiotherapy and S-1 for Older Patients With Esophageal Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06009705. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*